Overview

Spironolactone in Covid-19 Induced ARDS

Status:
Completed
Trial end date:
2020-07-05
Target enrollment:
Participant gender:
Summary
This study intended to evaluate the effects of commonly used diuretic, spironolactone, on oxygenation in covid-19 ARDS patients.
Details
Lead Sponsor:
Istanbul University-Cerrahpasa
Treatments:
Spironolactone